when the cure causes another painful disease

Please read and share.
Shared video from ATIP about our member Rhonda Posey.
Rhonda posted;
My hopes are to reach as many as possible who may be considering ESI’s or other invasive procedures in the spine and do not have all the facts needed to make an informed decision, and to reach those who may have this dreadful disease and are wondering what is happening to their bodies as I, and many others, did in the beginning.
The corticosteroids used in ESIs are NOT FDA approved for use in the epidural space, they are intended for intramuscular use only.

•The effectiveness and safety of injection of corticosteroids into the epidural space of the spine has not been established, and the FDA has not approved corticosteroids for this use.

Kenalog and Depo-medrol are the two leading corticosteroids used, manufacture package inserts include Arachnoiditis as an adverse effect on the data sheets.
—————————————————————–

4-23-2014 FDA Drug Communication issued the following statement;
•FDA requires label changes to warn of rare but serious neurological problems after epidural corticosteroid injections for pain
•The U.S. Food and Drug Administration (FDA) is warning that injection of corticosteroids into the epidural space of the spine may result in rare but serious adverse events, including loss of vision, stroke, paralysis, and death. The injections are given to treat neck and back pain, and radiating pain in the arms and legs. •We are requiring the addition of a Warning to the drug labels of injectable corticosteroids to describe these risks. Patients should discuss the benefits and risks of epidural corticosteroid injections with their health care professionals, along with the benefits and risks associated with other possible treatments.
——————————————————————
Yet patients are not told the risks or these very important facts to make an informed decision prior to signing informed consent. Knowing these facts could save your life.

4-23-2014 was the same day I showed this disturbing photo to my physician. It was the 2cd physician to confirm the diagnosis of Adhesive Arachnoiditis (AA). The 3rd would shortly follow from Dr. Forest Tennant, the leading expert authority of AA.

Arachnoiditis is not as rare as claimed. Due to overuse of epidural steroid injections, failed back surgeries, and other invasive procedures into the spine Dr. Tennant estimates that as many as one million Americans have this disease but go undiagnosed and misdiagnosed.

Be your own best advocate –be an informed patient.

Not just BAD CARE….but… incompetent healthcare providers ?

A psychopath surgeon kills and maims patients but somehow slips through the system. Scary. But here’s what’s even more terrifying.

ZPac, are you scared of retribution if you report impaired colleagues? How can we shift the culture?

Lying to Pts at the pharmacy counter ?

This is a comment made on the following post on my blog

Former CVS tech comes forward about lying to pts

This particular blog post has a total of a 187 comments since Feb 2015… This post may have the highest number of comments to a single post than any of the other  27,500 number of post on my blog.

“I went to have my prescription filled yesterday and was told they only had enough to fill half of it. So i called today to get the remainder.and was told it was to early to fill it . when they owed me half of my prescription for not having it in stock.”

According to the IP address of the person making this comment he/she lives in FLORIDA.  My understanding is that the DEA has changed the 72 hr to fulfill a partial C-II fill or forfeit the balance and in place there is now a 30 day period to get the balance, BUT.. a state has to change their state law to conform to the DEA law for it to be legal within a particular state and Florida has not done this.. so the 72 hr period remains in effect for Florida.

Under such situation(s) a pt needs to protect themselves. This could be as simple as the pharmacist wanting to impose their belief that the pt “does not need all of those opiates” and uses the excuse of “not enough inventory” and then one day later – “too early to refill”  This would suggest that it was the Pharmacist’s arbitrary interference with the pt getting the total number of doses that the prescriber had written for.

I was at a FL Board of Pharmacy meeting in June 2015 when a chronic pain doc asked the attorney for the BOP if it was illegal for a pharmacist to lie to a pt about having inventory on hand and the attorney responded that he was not aware that “issue” was not addressed in the state’s pharmacy practice act. So in FL, it would appear that UNPROFESSIONAL CONDUCT has a pretty high bar to be crossed in order to be accused/charged with UNPROFESSIONAL CONDUCT.

It could also be a situation of a pharmacist and/or technicians having a scheme of diverting opiates without it showing up on the store’s inventory. Remember that C-II opiates can have a “street value” of up to $1/mg.

What is a pt to do ? The pharmacy staff could have originally filled the Rx for HALF of the quantity written… and then reversed the claim and refilled it for the original amount and given and charged the pt for HALF of the Rx and pocketed/diverted the balance of the Rx.

Pt needs to call their insurance company and see what was actually billed by the pharmacy.  Verifying both the quantity and days supply was correctly submitted.

By law, the pharmacist/pharmacy is required to notify the prescriber of the quantity provided was less than was prescribed, if not… the pt could find themselves being accused of taking more medication than prescribed when they show up in two weeks instead of four requesting a new prescription.

Pt needs to ask that the prescriber run a state PMP report (Prescription Monitoring Program) that shows how many doses and the days supply that was submitted and if the report tracks if the Rx was paid for by insurance or cash .

Most chain stores have a dept called “loss prevention dept” and they would be interested in evidence that would suggest that their employees are involved in diversion of controlled meds.

If there is diversion involved, that could involve complaints to the BOP, DEA, Insurance company or Medicare/Medicaid if appropriate

Teamwork and technology: Facing the opioid epidemic head on

Teamwork and technology: Facing the opioid epidemic head on.

https://www.drugstorenews.com/pharmacy/teamwork-and-technology-facing-the-opioid-epidemic-head-on/

The Opioid epidemic paints a grim picture that is impossible to overlook: according to the provisional 2017 data from the National Institute on Drug Abuse, the U.S. had 49,068 opioid overdose deaths, more than any previous year on record.1 The number of deaths involving a prescription opioid pain reliever climbed to 19,354 in 2016. 1 The economic burden is thought to be $78.5 billion a year, extending from healthcare to the economy to the justice system and beyond.2

On a positive note, the industry has been heeding the frightening call to action: in 2017, the overall national opioid prescribing rate had fallen to the lowest it had been in more than 10 years at 58.7 prescriptions per 100 persons (total of more than 191 million opioid prescriptions). Even so, some counties had rates that were seven times higher than that in 2017.3

As providers are prescribing fewer of these medications, pharmacists are taking new leadership roles in an effort to combat the crisis. For most pharmacies, this battle has brought significant changes to the workflow and workload of its employees, taking its toll. To assist in the identification, mitigation, and management of opioid abuse risk factors, pharmacists can leverage new analytic technologies designed to minimize the epidemic’s toll on both patients and the community at large. New tools use big data to identify social groups and other “teams” of schemers who work together to perpetuate the dangerous cycle of drug availability and abuse.

High-risk entities

Knowledge is power. Today’s available data streams — when applied strategically — highlight previously unknown details about the highest-risk stakeholders in the opioid epidemic.

Patients

Our patients, or healthcare consumers, are the most at-risk group in this dangerous equation. At-risk patients include individuals who are new to taking the opioid prescription type, as well as individuals who are intentionally abusing the drug or using it recreationally. Other consumers, albeit a small subset but the more dangerous type, are those who may acquire medications in order to sell them on the black market or to known contacts.

Patients can also be part of social groups which represent clusters or networks of individuals who work in tandem to drive drug diversion on a widespread level. Social groups can be uncovered by outside data technologies that reveal common links, such as the patient’s friends; family members; colleagues; and associates from various walks of life. Using such public records data sets, technology can pinpoint socialization patterns and layer on the footprint and the network of information associated in order to surface active entities and/or clusters of potential abusers or traffickers.

According to the Centers for Disease Control and Prevention, drug diversion, the transference of legally controlled and prescribed substances from one individual to another, is the number one avenue for opioid abuse. It’s critical for pharmacies to hone in on the largest source of potential risk: the social ties that remain present in the complex web of opioid interactions. Using analytics, technology goes outside the realm of health data and into traditional, non-medical sources of information to help identify unknown circumstances, risks, and questionable behaviors that contribute to the proliferation of opioids within the industry.

Prescribers

Providers play a key role in minimizing the number of prescriptions written and identifying the types of patients most at risk for fraud and abuse. Many errant provider behaviors are seemingly innocuous and simply require re-education. Inadvertently, physicians may write scripts for high-risk patients and even to family members of such patients. Other times, perilous actions are more intentional, such as writing opioids for friends and family members, or writing excessive quantities of certain drug types. Analytics, such as real-time prescriber verification, provider-patient socialization and patient record matching, can help capture these data points and flag specific situations to surface and demonstrate provider risk.

Pill Mills

Pill mills are truly a “team effort” of multiple high-risk entities, including patients, providers, and pharmacies who work to dispense drugs inappropriately or for non-medical reasons. It’s a collaborative and complicated operation that requires intense visibility of numerous factors, players, and environments. It’s a perfect scenario for application of data analytics, which can search across both provider claims and outside data sources to determine:

  • prescribers who are treating high percentages of patients receiving high-risk drugs;
  • pharmacies that are filling excessive numbers of scripts for these medications; and
  • prescribers and pharmacies that may be unknowingly participating in a pill mill operation by providing care to a large, specific social network who have organized to obtain large quantities of drugs for misuse.

 

Prevention tools

Pill mills often rely on “frequent fliers” or “doctor shoppers” who go to providers and pharmacies in close succession to divert drugs for resale and abuse. Other times, these individuals engage in risky behaviors to support a drug habit or to divert drugs to family or relatives in their social circle. The key here is that a social group can be identified through mutual history, joint employment or ownership, shared organizations and others. These insights can reveal a large-scale operation in high-risk patient and provider networks. By analyzing the data, technology identifies the risk represented by the entire network, revealing that seemingly “innocent” players are actually participants in a larger scheme.

By looking across drugs to determine net unsafe MEDs calculations, pharmacies can offer transparency about the other drugs a patient is being prescribed and indicate potential situations of diversion, abuse, or health risk. These figures can and should be tracked through technology — as should the MEDs totals of others within a patient’s social network—to identify the potential for abuse.

In addition to uses we have been discussing, analytics can play an important, proactive role during healthcare benefits enrollment, at point-of-service interactions, and through claims analysis – after care has been provided.  Understanding what occurred, when it occurred, and why gives all stakeholders information that may prevent an adverse event in the future.

Through industry-wide collaboration and availability of disparately sourced health and public records, we have an opportunity to learn more about the patterns of opioid abuse and to potentially help stop it in its tracks. The benefits of data sharing far outweigh the risks, so what are we waiting for?

Life: quality or quantity… One.. Both… Neither… decided by someone else ?

I have a chronic illness and suffer from non stop pain. Last March, when my father was dying and I was flying back and forth to Montana I spoke to my pain management people about the 15 plus hour flights. I explained the increased strain, pain, and stress I was under. (One flight actually got way laid till the next day and I was in Salt Lake for a day. I was super bruised in both hips and on each side of my back and spine from the seats. ) I had asked my PM to help me temporarily with something to ease the pain as I was getting ready to go back up to Montana. My dad was now in hospice. They said no. Not gonna help me. Told me that if I didn’t like it then don’t fly. My chart was flagged. I was labeled a risk because I asked. Then I changed to medicaid insurance and they dropped me without a second thought. Hung up on me when I called and asked about the insurance. So I was cold turkey off all my pain meds. Now all this being said….
I understand someone going though with “END OF LIFE” proceedings. It is not, NOT suicide so don’t even think that. Suicide is for people who are self haters.
We are not self haters. We love life, our families and, friends, but when your body is so wracked with pain that you just can’t move anymore, and the slightest movement can make you puke. When you have to have help to the bathroom because your legs or feet are in so much pain you can’t stand. THEN TO HAVE THEN ONLY RELIEF FROM THIS CONSTANT NEVER ENDING SUFFERING RIPPED FROM YOU and to labeled a drug addict by the very dr who has been treating you for years? There comes a point where there is no quality of life, no end in sight, and we have to make a decision to what’s right for ourselves and our families.
I personally have thought about turning to street drugs to ease my pain because it’s cheaper than the medical marijuana that I have been prescribed here in FL. I just can’t bring myself to do.
I can’t go back on opioids.
I do have an END OF LIFE EXIT PLAN.

The above comment was made on this post on my blog  Ray left us this morning. He decided he couldn’t live with the Pain anymore

Somewhere I remember is some class that:

we Americans were entitled to “Life, Liberty and the Pursuit of Happiness”

We are innocent until proven guilty and we are entitled to a “speedy trial”

The 4th Amendment prohibits unreasonable search and seizure

The 8th Amendment prohibits the federal government from imposing excessive bail, excessive fines, or cruel and unusual punishments.

Most of the time in dealing with the enforcement of many laws.. is that those who create our laws and those that are in charge of enforcing our laws are the same ones who are breaking the laws and/or have decided not to enforce the laws or only enforce certain laws at certain times and/or against certain individual(s) or groups.

When the DEA raids and closes a practice… are the chronic pain pts of that practice being exposed to cruel and unusual punishment … because generally no other prescriber will take them on as a pt because generally the DEA has seized the pt’s medical records and put up road blocks for the pt to get them and/or a copy of them….  Unless one does not consider a cold turkey withdrawal as “cruel and unusual punishment” particularly for someone who is innocent until proven guilty.

How many pts suffering with a chronic disease would chose quantity of life without any quality of life and how many of those same pts would chose a good quality of life even if it could compromise their quantity of life ?

How much longer is the chronic pain community continue to whine, bitch and moan about being the “innocent victims” of the war on drugs..  why is most of the healthcare system not fighting to protect themselves and their pts ?

Maybe it is time for the chronic pain community to get to funding a legal defense fund and start suing those parts of the healthcare system that are responsible for denial of care and torturing the innocent chronic pain pts…  These entities will react to whoever they fear the most… right now it is the DEA… but .. it’s just as easy to be chronic pain pts… which could force them to stand up to the DEA and other bureaucratic entities that are violating the laws they are in charge of enforcing.

Others should not be the ones who are deciding if chronic pain pts should have a quality of life or a quantity of life nor have NEITHER !

 

 

 

Revolutionary new blood test can instantly identify chronic pain

A new blood test that can identify chronic pain could revolutionize diagnoses for humans and animals

Revolutionary new blood test can instantly identify chronic pain

https://newatlas.com/blood-test-chronic-pain/54507/

A world-first blood test that can objectively identify chronic pain has been developed by a team of Australian researchers. The test can reportedly identify color changes in immune cells affected by chronic pain and hopefully give doctors a new way to diagnose the severity of pain in patients unable to adequately communicate it.

“This gives us a brand new window into patients’ pain because we have created a new tool that not only allows for greater certainty of diagnosis but also can guide better drug treatment options,” explains lead on the new research, neuroscientist Mark Hutchinson, who is Director of the Australian Research Council Centre of Excellence for Nanoscale BioPhotonics at the University of Adelaide.

The research team found that there are identifiable molecular changes in immune cells when a person is suffering from chronic pain. Using hyperspectral imaging analysis these pain biomarkers can be instantly identified, meaning a clinician could determine a patient’s pain tolerance or sensitivity and immediately adjust the dosage of a painkilling medication.

“We are literally quantifying the color of pain,” says Hutchinson. “We’ve now discovered that we can use the natural color of biology to predict the severity of pain. What we’ve found is that persistent chronic pain has a different natural color in immune cells than in a situation where there isn’t persistent pain.”

As well as offering a new biomarker for the presence of pain, Hutchinson’s research suggests that these immune cells actually play a significant role in modulating the sensation of chronic pain. This means that instead of concentrating on developing pain-killing drugs that simply target the nervous system, new drugs may be investigated that suppress this immune pain response.

“We now know there is a peripheral cell signal so we could start designing new types of drugs for new types of cellular therapies that target the peripheral immune system to tackle central nervous system pain,” says Hutchinson.

The test, called “painHS”, could potentially be ready to roll out into broad clinical use within 18 months, but the broader implications of this kind of objective blood test for pain is where things get really interesting. Hutchinson hopes this test could assist in diagnosing pain in subjects that cannot communicate their discomfort, from babies to older sufferers of dementia. The test may also be applicable to animals, which Hutchinson suggests could revolutionize the entire field of veterinary treatment.

“Animals can’t tell us if they’re in pain but here we have a Dr Dolittle type test that enables us to ‘talk’ to the animals so we can find out if they are experiencing pain and then we can help them,” says Hutchinson.

The new test was revealed at the Faculty of Pain Medicine (FPM) conference in Sydney over the weekend.

 

 

Fear of Addiction Phobia – Tuesday, October 16, 2018 8pm est www.cawnation.com

Image may contain: text

THE DOCTOR’S CORNER
w/ DR. KLINE & JONELLE ELGAWAYTopic: Fear Of Addiction PhobiaCall in with questions at
(415) 915-2291

Tune in at
www.cawnation.com OR
YT Channel: The Doctor’s Corner

San Francisco to Vote on Taxing Rich Businesses for Homeless

San Francisco to Vote on Taxing Rich Businesses for Homeless

https://www.usnews.com/news/cities/articles/2018-10-15/san-francisco-to-vote-on-taxing-rich-businesses-for-homeless

San Francisco voters have a measure on the Nov. 6 ballot that would tax hundreds of the city’s wealthiest companies to help thousands of homeless and mentally ill.

The Associated Press

In this Oct. 1, 2018 photo, Stormy Nichole Day, left, sits on a sidewalk on Haight Street with Nord (last name not given) and his dog Hobo while interviewed about being homeless in San Francisco. A measure on San Francisco’s Nov. 6 ballot would levy an extra tax on hundreds of the city’s wealthiest companies to raise $300 million for homelessness and mental health services. It’s the latest battle between big business and social services advocates who say that companies such as Amazon, Google and Salesforce can afford to help solve severe inequities caused by business success

SAN FRANCISCO (AP) — San Francisco has come to be known around the world as a place for aggressive panhandling, open-air drug use and sprawling tent camps, the dirt and despair all the more remarkable for the city’s immense wealth.

Some streets are so filthy that officials launched a special “poop patrol,” and a young tech worker created “Snapcrap” — an app to report the filth. Morning commuters walk briskly past homeless people huddled against subway walls. In the city’s squalid downtown sector, the frail and sick shuffle along in wheelchairs or stumble around, sometimes half-clothed.

The situation has become so dire that a coalition of activists collected enough signatures to put a measure on the city’s Nov. 6 ballot. Proposition C would tax hundreds of San Francisco’s wealthiest companies to help thousands of homeless and mentally ill residents, an effort that failed earlier this year in Seattle. San Francisco’s measure is expected to raise $300 million a year, nearly doubling what the city already spends.

“This is the worst it’s ever been,” says Marc Benioff, founder of cloud-computing giant Salesforce and a fourth-generation San Franciscan, who is supporting the measure even though his company would pay an additional $10 million a year if it passes. “Nobody should have to live like this. They don’t need to live like this. We can get this under control.”

“We have to do it. We have to try something,” said Sunshine Powers, who owns a tie-dye boutique, Love on Haight, in the city’s historic Haight-Ashbury neighborhood. “If my community is bad, nobody is going to want to come here.”

The proposition is the latest battle between big business and social services advocates who demand that corporate America pay to solve inequities exacerbated by its success. In San Francisco, it’s also become an intriguing fight between recently elected Mayor London Breed, who is siding with the city’s Chamber of Commerce in urging a no vote, and philanthropist Benioff, whose company is San Francisco’s largest private employer with 8,400 workers.

Breed came out hard against the measure, saying it lacked collaboration, could attract homeless people from neighboring counties, and could cost middle-class jobs in retail and service. The city has already dramatically increased spending on homelessness, she said, with no noticeable improvement.

San Francisco spent $380 million of its $10 billion budget last year on services related to homelessness.

“I have to make decisions with my head, not just my heart,” Breed said. “I do not believe doubling what we spend on homelessness without new accountability, when we don’t even spend what we have now efficiently, is good government.”

Cities along the West Coast are grappling with rampant homelessness, driven in part by growing numbers of well-paying tech jobs that price lower-income residents out of tight housing markets. A family of four in San Francisco earning $117,000 is considered low-income.

Business prevailed in Seattle, when leaders in June repealed a per-employee tax that would have raised $50 million a year, after Amazon and Starbucks pushed back. In July, the city council of Cupertino in Silicon Valley scuttled a similar head tax after opposition from its largest employer, Apple Inc.

Mountain View residents, however, will vote this fall on a per-employee tax expected to raise $6 million a year, largely from Google, for transit projects.

The San Francisco measure is different in that it would levy the tax mostly by revenue rather than by number of employees — an average half-percent tax increase on companies’ revenue above $50 million each year. It was also put on the ballot by citizens, not elected officials.

Online payment processing company Stripe has voiced opposition and contributed $120,000 to the campaign against Proposition C, but other companies have stayed quiet. The San Francisco Chamber of Commerce, whose board includes representatives of Microsoft, LinkedIn and Oracle, is leading the fight.

Up to 400 businesses would be affected, with internet and financial services sectors bearing nearly half the cost.

The city says confidentiality precludes revealing tax information, but some of the companies expected to pay the most are big names across major industries. Wells Fargo & Co., retailer Gap Inc. and ride-hailing platform Uber declined to comment.

Pharmaceutical distributor McKesson Corp. referred questions to a private-sector trade association, the Committee on Jobs, which called the measure flawed. Utility Pacific Gas & Electric Corp. said it has not taken a position. Twitter declined to comment, but chief executive Jack Dorsey said via tweet last week that he trusts Breed to fix the problem.

“Anyone can take a look at the status quo and understand it’s not working, but more money alone is not the sole answer,” says Jess Montejano, spokesman for the “No on C” campaign.

Where Tech Employment Is Booming

Benioff disagrees. A $37 million two-year initiative he helped start with the city and to which he contributed more than $11 million has housed nearly 400 families through rent subsidies, he said.

Benioff has pledged at least $2 million from company and personal resources for the November tax campaign. He said he was ultimately swayed by a report from the city’s chief economist, which found the measure would likely reduce homelessness while resulting in a net loss of 900 jobs at most, or 0.1 percent of all jobs.

“I said, ‘Well, I’m the largest employer in the city, and the city is in decline from homelessness and cleanliness. We have to take action now,’ ” he said.

At least half of the new revenue would go toward permanent housing, and at least a quarter to services for people with severe behavioral issues. A 2017 one-night count found an estimated 7,500 people without permanent shelter in San Francisco. More than half had lived in the city for at least a decade.

Tracey Mixon and her daughter, Maliya, 8, are among the hidden homeless.

Mixon, 47, a San Francisco native, lives and works in the notoriously dangerous and drug-infested Tenderloin neighborhood. They were forced out of their rental this summer, partly because the company that managed her property lost its federal accreditation, she said on a recent afternoon while working a crossing guard shift.

One of the hardest parts was finding a place to go for the day when mother and daughter were kicked out of an overnight-only emergency shelter.

“I have to shield her from people that are using drugs,” she said. “I have to shield her from people who might be fighting.”

Hanging out on Haight, the street that played a central role in the “Summer of Love,” Stormy Nichole Day, 22, says she would love a place to live. Currently, Day is sleeping in a doorway. She could thrive if her basic needs were met, she said.

“And that includes a house, and a place to cook food and a place to take a shower.”

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

There seems to be NO END to the categories that bureaucrats tries to tax to pay for some sort of “social war” ..

Some bureaucrats have implemented a “soda/sugar tax” and they even tax DIET SODA .. don’t remember what they were going to use this money on

Some bureaucrats have proposed a “opiate Rx tax” to help pay for the treatment of those substance abusers/addicts

San Francisco is proposing that they tax “rich businesses” to pay for the upkeep of the homeless in San Francisco.

what service(s) or products will they come up with next to tax to help solve some “social evil”

 

Palliative Care Clinical Practice Guidelines (2018)

Palliative Care Clinical Practice Guidelines (2018)

http://reference.medscape.com/viewarticle/902333

The fourth edition of palliative care clinical practice guidelines from the National Consensus Project for Quality Palliative Care are scheduled to be published on October 31, 2018.[1]

Structure and Processes of Care

Being holistic in nature, palliative care is provided by a team of physicians, advanced practice registered nurses, physician assistants, nurses, social workers, and chaplains.

A comprehensive interdisciplinary assessment of the patient and family forms the basis for the development of an individualized patient and family palliative care plan.

In collaboration with the patient and family, the interdisciplinary team (IDT) develops, implements, and updates the care plan to anticipate, prevent, and treat physical, psychological, social, and spiritual needs.

Palliative care is provided in any care setting, including private residences, assisted living facilities, rehabilitation settings, skilled and intermediate care facilities, acute and long-term care hospitals, clinics, hospice residences, correctional facilities, and homeless shelters.

Physical Aspects of Care

The IDT assesses physical symptoms and their impact on well-being, quality of life, and functional status.

Interdisciplinary care plans are developed in the context of the patient’s care goals, disease, prognosis, functional limitations, culture, and care setting.

Essential components of palliative care are ongoing management of physical symptoms, anticipation of health status changes, and monitoring of potential risk factors associated with the disease and with side effects resulting from treatment regimens.

The palliative care team provides written and verbal recommendations for monitoring and managing physical symptoms.

Psychological and Psychiatric Aspects of Care

The IDT includes a social worker with the ability and skill set to assess and support mental health issues, provide emotional support, and address emotional distress and quality of life for patients and families experiencing the expected responses to serious illness.

The IDT screens for and assesses psychological and psychiatric aspects of care based on the best available evidence, to maximize patient and family coping and quality of life.

The IDT manages and/or supports psychological and psychiatric aspects of patient and family care, including emotional or existential distress, related to the experience of serious illness, as well as identified mental health disorders.

Social Aspects of Care

The IDT screens for and assesses patient and family social supports, social relationships, resources, and care environment based on the best available evidence, to maximize coping and quality of life.

A palliative care plan addresses the ongoing social aspects of patient and family care in alignment with the goals of the patient and family and provides recommendations to all clinicians involved in ongoing care.

Spiritual, Religious, and Existential Aspects of Care

Patient and family spiritual beliefs and practices are assessed and respected. Palliative care professionals acknowledge their own spirituality as part of their professional role and are provided with education and support to address each patient’s and family’s spirituality.

The spiritual assessment process has three distinct components—spiritual screening, spiritual history, and a full spiritual assessment. Symptoms, such as spiritual distress, as well as spiritual strengths and resources, are identified and documented.

Patient and family spiritual care needs can change as the goals of care change or patients move across settings of care.

Cultural Aspects of Care

The IDT delivers care that respects patient and family cultural beliefs, values, traditional practices, language, and communication preferences and builds on the unique strengths of the patient and family.

The IDT ensures that the patient’s and family’s preferred language and style of communication are supported and facilitated in all interactions.

The IDT uses evidence-based practices when screening and assessing patient and family cultural preferences regarding healthcare practices, customs, beliefs and values, level of health literacy, and preferred language.

A culturally sensitive plan of care is developed and discussed with the patient and/or family. This plan reflects the degree to which patients and families wish to be included as partners in decision-making regarding their care.

Care of the Patient Nearing the End of Life

The IDT includes professionals with training in end-of-life care, including assessment and management of symptoms, communication with patients and families about signs and symptoms of approaching death, transitions of care, and grief and bereavement.

The IDT assesses physical, psychological, social, and spiritual needs as well as patient and family preferences regarding setting of care, treatment decisions, and wishes during and immediately following death.

In collaboration with the patient and family and other clinicians, the IDT develops, implements, and updates as needed a care plan to anticipate, prevent, and treat physical, psychological, social, and spiritual symptoms. All treatments are provided in a culturally and developmentally appropriate manner.

During the dying process, patient and family needs are respected and supported. Postdeath care is delivered in a manner that honors the patient’s and family’s cultural and spiritual beliefs, values, and practices.

Prepared in advance of the patient’s death, a bereavement care plan for the family and care team is activated after the death of the patient and addresses immediate and longer-term needs.

Ethical and Legal Aspects of Care

The core ethical principles of autonomy, substituted judgment, beneficence, justice, and nonmaleficence underpin the provision of palliative care.

The provision of palliative care occurs in accordance with federal, state, and local regulations and laws, as well as with current accepted standards of care and professional practice.

The patient’s preferences and goals for medical care are elicited using core ethical principles and are documented.

Within the limits of applicable state and federal laws, current accepted standards of medical care, and professional standards of practice, person-centered goals form the basis for the plan of care and decisions related to providing, forgoing, and discontinuing treatments.

A couple months ago our sister Michelle Bloem committed suicide due to uncontrolled pain- a GENOCIDE ?

Image may contain: 2 people, people smiling, text

A couple months ago our sister Michelle Bloem committed suicide due to uncontrolled pain. Before she was murdered for the sake of ‘preventing addiction’, Michelle wrote this:

To whom it may concern,

I have CRPS/RSD and am currently seeing a doctor that monitors my progress and medications. I was diagnosed in June of 2010. After trying every treatment modality including physical therapy, anti-seizure medications, biofeedback, etc. I was put on OxyContin. After having 8 brachial plexus nerve blocks and 5 lumbar nerve blocks, my neurologist/ pain management doctor kept upping the dosage of it because I was getting no relief and we could not figure out why. He ended up upping the dosage so much I was only experiencing side effects, no pain relief. I decided to leave my pain management doctor at UCLA and seek out another doctor that could find out why I wasn’t getting any pain relief. I finally found a doctor that did many tests on me including: Neuroinflamation blood tests, Genetic malabsorption blood work-up. My doctor was able to figure out that I cannot absorb oral opioids due to a genetic malabsorption defect. He put me on a trial of subcutaneous dilaudid. I had experienced instant pain relief and received my quality of life back. I have been on this medication for two years with no side effects. This medication has to be compounded, which my new insurance will not pay for. Dr. Tennant has saved my life and given me my life back. You must understand that we chronic pain patients cannot be punished for the people that use opioids illegally. None of us “want” to be on these medications, but have no choice. After trying everything, we just want quality of life. The restrictions that are already put in place are making it harder and harder for the legitimate chronic pain patients to get their medications that give them quality of life. Please consider that we are carefully monitored by our doctors and take our medications as prescribed only. We should not be punished for the street abusers that only want a “high”. I have never experienced a “high” from my pain medicine. There are studies in the process that have to do with different medications to help us, but it takes an extremely long time to get them FDA approved. In closing, I hope you will kindly consider our circumstances, that we have families, and only want to be able to participate in daily activities without suffering inhumanly.

Thank you,

Michelle Bloem

Michelle died directly because of the policies and practices of people like @AndrewKolodny, The CDC, Organizations like #PROP, and the policies of people like Chris Christie and the #POTUS @realDonaldTrump. Chronic pain patients are dying because of the policies our government imposes to curb the illegal use of opiates. Just because we suffer from chronic, debilitating pain does not make us criminals. We take medications, under the supervision of multiple doctors, to improve our quality of life. Chronic pain patients are being forced to take their lives as their only means of pain management. Please stop the genocide of chronic pain patients!!